| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |